MarkRJ, PoenJC, TranLM, et al.Angiosarcoma: a report of 67 patients and a review of the literature. Cancer, 1996; 77(11):2400–2406. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z
2.
ShustefE, KazlouskayaV, PrietoVG, et al.Cutaneous angiosarcoma: a current update. J Clin Pathol, 2017; 70(11):917–925. doi: 10.1136/jclinpath-2017-204601
3.
SelimA, KhachemouneA, LockshinNA. Angiosarcoma: a case report and review of the literature. Cutis, 2005; 76(5):313–317. https://doi.org/10.1155/2014/657876
4.
CaoJ, WangJ, HeC, et al.Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res, 2019; 9(11):2303–2313. https://doi.org/10.3389/fsurg.2022.966792
5.
AmayaCN, PerkinsM, BelmontA, et al.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. Oncoscience, 2018; 5(3–4):109–119. doi: 10.18632/oncoscience.413
